HR 5416 The Give Kids a Chance Act (H.R. 5416) amends the RACE for Children Act to authorize FDA to require pediatric study plans not only for single cancer therapies, but also for combinations of cancer therapies. It also authorizes FDA to require preclinical studies.
Collaboration to Cure Medulloblastoma
Curemedullo Is A Division Of The Carson Leslie Foundation ©2021 All rights reserved. The Carson Leslie Foundation (CLF) is a registered 501(c)(3) charity organization. Please note that cureMEdullo provides this information for the benefit of the medulloblastoma and childhood cancer community. cureMEdullo and CLF are not medical providers or a health care facility and thus can neither diagnose any disease or disorder nor endorse or recommend any specific medical treatments. Patients must rely on the personal and individualized medical advice of their qualified health care professionals before seeking any information related to their particular diagnosis, cure or treatment of a condition or disorder.